Malaria fighters gather at site of early victory.
Bagla
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000349:Africa; D000818:Animals; D030801:Animals, Genetically Modified; D000852:Anopheles / Q000235:genetics* / Q000469:parasitology; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007194:India; D007303:Insect Vectors / Q000235:genetics / Q000469:parasitology; D008288:Malaria / Q000150:complications / Q000188:drug therapy; D010961:Plasmodium / Q000235:genetics / Q000502:physiology
D000962:Antimalarials; D006634:Histamine H1 Antagonists; D002744:Chlorpheniramine; D002738:Chloroquine